Gabe Holdsman is currently Senior Vice President, Global General Counsel for PTC Therapeutics, Inc., a science-driven, global pharmaceutical company.

Gabe is a Drexel University alumnus. He started his legal career at Conrad O’Brien, a Philadelphia litigation firm. His first in-house assignment was with AmerisourceBergen, a global pharmaceutical wholesaler and distributor. He later joined Auxilium Pharmaceuticals, a publicly-traded specialty pharmaceutical company (subsequently acquired by Endo), and then BTG, a London-based publicly-traded pharmaceutical and medical device company (subsequently acquired by Boston Scientific). Gabe joined PTC in 2018.